1. Biology

Stairway to the Golgi: Two paths VPS13B can go by

Written by Posted on Less than 0 min read

VPS13 proteins mediate lipid transfer across membranes. Among them, VPS13B is associated with Golgi membranes, and VPS13B mutations cause Cohen syndrome. In this issue, Ugur et al. (https://doi.org/10.1083/jcb.202311189) and Du et al. (https://doi.org/10.1083/jcb.202402083) reveal new VPS13B interactors and their functions in Golgi organization and trafficking.

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Flamingos don’t preen more than other waterbirds

Despite their famously fancy feathers, flamingos don’t spent more time preening than other waterbirds, new research shows. Scientists watched five of the world’s six flamingo species to see how they spend their time. While preening time varied, overall flamingos were roughly average compared to existing studies of other waterbirds. The researchers also examined time spent […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

American lobster population, habitat preferences shifting, study finds

American lobsters along Maine’s coast have relocated to new habitats, while the population simultaneously shrunk in abundance and grew older, according to a new study by University of Maine researchers. For decades, the vast majority of adult lobsters resided in boulder shelter habitats. This knowledge helped inform longtime conservation efforts and regulations within the more […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Researchers find ideal place to take reptiles’ pulse rate

Cornell University researchers have discovered they can consistently measure reptiles’ pulse rate in an easy-to-reach spot on the back of the head, and that pulse rate corresponds to the heart rate in healthy reptiles. The technique requires an ultrasonic Doppler flow detector, a common instrument found in most veterinary clinics. While the location to obtain […]
Written by
Positive Link Identified Between SARS-CoV-2 and Guillain-Barré
  1. Life Sciences

Positive Link Identified Between SARS-CoV-2 and Guillain-Barré

By Elana Gotkine HealthDay Reporter WEDNESDAY, Oct. 18, 2023 — There is a positive association for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Guillain-Barré syndrome (GBS), and a negative association for COVID-19 vaccination and GBS, according to a study published online Oct. 18 in Neurology. Haya Bishara, from the Lady Davis Carmel Medical […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Last surviving woolly mammoths were inbred but not doomed to extinction

The last population of woolly mammoths was isolated on Wrangel Island off the coast of Siberia 10,000 years ago, when sea levels rose and cut the mountainous island off from the mainland. A new genomic analysis reveals that the isolated mammoths, who lived on the island for the subsequent 6,000 years, originated from at most […]
Written by
  1. Nonclinical

Beyond patient care: Unlocking the potential of nonclinical careers for physicians

Title: Beyond Patient Care: Unlocking the Potential of Nonclinical Careers for Physicians Introduction: The medical field offers a diverse range of career paths beyond traditional patient care, providing physicians with ample opportunities to utilize their expertise and make a lasting impact in various nonclinical roles. Exploring these alternative career paths not only contributes to the […]
Written by
  1. Nonclinical

Beyond Patient Care: A Look into Nonclinical Healthcare Careers

Beyond Patient Care: A Look into Nonclinical Healthcare Careers The field of healthcare is often associated with direct patient care, such as doctors, nurses, and other medical professionals. However, the healthcare industry offers a diverse range of fulfilling career options beyond the traditional roles. These nonclinical healthcare careers play a critical role in supporting patient […]
Written by
  1. Pharmaceuticals and Drug Development

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational… Admin Member since October 11, 2023 Loading + Follow Following
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome

Treatment for: WHIM Syndrome X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) –X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the United States Food and Drug […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism

Generic name: palopegteriparatideTreatment for: Hypoparathyroidism Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA) notified the Company that information submitted in response […]
Written by
  1. Clinical

Amylyx Prescribed drugs Publicizes Interim Information From Ongoing Part 2 HELIOS Scientific Trial Demonstrating Enhancements in Pancreatic Operate and Glycemic Management with AMX0035 in Individuals with Wolfram Syndrome

CAMBRIDGE, Mass.–(BUSINESS WIRE) April 10, 2024 — Amylyx Prescribed drugs, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Firm”) immediately introduced interim information from the continued Part 2 HELIOS scientific trial of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO, also known as ursodoxicoltaurine]) in adults dwelling with Wolfram syndrome, a uncommon, progressive genetic illness impacting roughly 3,000 […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

US Study Reveals CP-GEP’s Profound Impact on Stratifying Melanoma Patients for Long-Term Survival

ROTTERDAM, Netherlands and SAN DIEGO, Nov. 6, 2023 . SkylineDx, an innovative molecular diagnostics company, is pleased to announce the forthcoming presentation of an impactful poster by Dr M.E. Egger at the upcoming Society for Melanoma Research Congress in Philadelphia. Dr. M.E. Egger’s presentation promises to usher in a new paradigm in disease staging and […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Datopotamab Deruxtecan Improved Progression-Free Survival vs. Chemotherapy in Patients with Previously Treated Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

TROPION-Lung05 resultsInitial results from the TROPION-Lung05 Phase II trial showed datopotamab deruxtecan demonstrated encouraging antitumour activity in patients with heavily pretreated locally advanced or metastatic NSCLC with actionable genomic alterations including those with EGFR mutations and anaplastic lymphoma kinase (ALK) rearrangements. These data were presented at the ESMO 2023 Congress on Saturday, 21 October (1314MO). […]
Written by
  1. Clinical

Prota Therapeutics Announces Publication in Allergy of Long-Term Peanut Allergy Study Confirming Clinical Remission as the Optimal Treatment Outcome

MELBOURNE, Australia, Aug. 14, 2024. Prota Therapeutics Pty Ltd (Prota), an Australian clinical-stage biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced publication in the journal Allergy of the first long-term study directly comparing remission and desensitization endpoints following food allergen oral immunotherapy (OIT). The Phase […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

REGENXBIO Presents Positive One Year Data from Phase II ALTITUDE Trial of ABBV-RGX-314 for Treatment of Diabetic Retinopathy

ROCKVILLE, Md., Nov. 4, 2023. REGENXBIO Inc. today announced additional positive data from the ongoing Phase II ALTITUDE trial of ABBV-RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular edema (CI-DME) using in-office suprachoroidal delivery. The data will be presented at the American Academy of Ophthalmology meeting in San Francisco, CA by […]
Written by
  1. Biology

Agriculture accelerated human genome evolution to capture energy from

Over the past 12,000 years, humans in Europe have dramatically increased their ability to digest carbohydrates, expanding the number of genes they have for enzymes that break down starch from an average of eight to more than 11, according to a new study by researchers from the U.S., Italy and United Kingdom. Over the past […]
Written by
  1. Biotechnology

Synthesis of SiOC@C ceramic nanospheres with tunable electromagnetic wave

In recent years, microwave technology has dramatically progressed, marked by the arrival of the 5G era, owing to the advantages of electromagnetic waves in long-distance, wireless, and high-speed transmissions. However, electromagnetic wave pollution problems such as electromagnetic wave interference and electromagnetic wave radiation are becoming increasingly serious. Electromagnetic wave pollution not only affects the normal […]
Written by
  1. Biotechnology

Few anti-immigration users dominate most of UK-based anti-immigration

A study of more than 200,000 tweets from 2019 and 2020 finds that anti-immigration content spreads faster than pro-immigration tweets and that a few users disproportionally generated most of the UK-based anti-immigration content. Andrea Nasuto and Francisco Rowe of the Geographic Data Science Lab at the University of Liverpool, UK, present these findings in the […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Stairway to the Golgi: Two paths VPS13B can go by

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.